News | October 09, 2007

Thoracic Imaging Pinpoints Underlying Venous Problems

October 10, 2007 - A new technique for capturing images of chest veins eases diagnosis of venous diseases, according to a study presented by University of Cincinnati (UC) radiologists at the North American Society of Cardiovascular Imaging's 35th Annual Meeting and Scientific Sessions in Washington, D.C.
Developed by Cristopher Meyer, M.D., and Achala Vagal, M.D., the new protocol allows radiologists to compensate for the extra time it takes contrast solution to reach the veins so useful images can be produced using the CT scanner.
“We found that the rapid-imaging scanners were almost too fast for venous studies,” explained Vagal, a UC assistant professor and radiologist at University Hospital. “By the time the contrast reached the patient’s veins, there were too many artifacts to make any meaningful conclusions about possible disease - for example, blood clots.”
Venous disease is rare and can be difficult to pinpoint, noted Vagal. “This new protocol uses the same imaging equipment in a novel way that allows us to acquire better venous images and make good clinical decisions,” said Vagal, who presented guidelines for this thoracic imaging protocol at the meeting.
For this new imaging technique, the CT technologist prepares two syringes of contrast: The first includes 140 cubic centimeters (CC) of undiluted contrast; the second contains a diluted mixture of 100 CC of contrast and 10 CC of saline solution.
"The key to getting accurate clinical images of the veins is in the timing," Vagal indicated.
Both syringes are given consecutively at a rate of four CC per second, with a 60-second delay between the final injection and initiation of the CT scan.
"Previously, there was so much dense contrast in the veins that all you could see on the CT scan were streaks that didn't tell you anything about possible venous disease," explained Vagal. "Delaying the scan gave us enough time for both the arteries and the veins to be opacified, which resulted in the crisp images that allowed us to make better clinical determinations."

For more information: www.med.uc.edu


Related Content

News | Computed Tomography (CT)

April 22, 2024 — A new study showed that a non-invasive imaging test can help identify patients with coronary artery ...

Home April 22, 2024
Home
Feature | Computed Tomography (CT) | By Alberto Morales, MD

Cardiac CT scans, recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA) as ...

Home March 20, 2024
Home
News | Computed Tomography (CT)

February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

Home February 20, 2024
Home
News | Computed Tomography (CT)

HeartFlow is offering a free webinar based on a recent study that measured the ability of the of its roadmap analysis to ...

Home January 15, 2024
Home
News | Computed Tomography (CT)

December 19, 2023 — Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the Somatom Pro ...

Home December 19, 2023
Home
Feature | Computed Tomography (CT) | By Andrew Michalski, PhD and Rohit Sood MD, PhD

Coronary artery disease (CAD), also known as ischemic heart disease, is the most common heart disease with a prevalence ...

Home December 05, 2023
Home
News | Computed Tomography (CT)

October 26, 2023 — HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care ...

Home October 26, 2023
Home
News | Computed Tomography (CT)

October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and ...

Home October 13, 2023
Home
News | Computed Tomography (CT)

September 29, 2023 —Nano-X Imaging, an innovative medical imaging technology company, today announced that HealthCCSng ...

Home September 29, 2023
Home
News | Computed Tomography (CT)

September 19, 2023 — An advanced CT test can identify individuals with stable angina at a reduced risk of three-year ...

Home September 19, 2023
Home
Subscribe Now